REF:

C8101 (Strip)

C8102 (Cassette)

INTENDED USE：

Opiate Urine Test is a lateral flow chromatographic immunoassay for the detection of Opiates in human urine at the cut-off concentration of 2,000 ng/ml. This test will detect other compounds, please refer to Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

SUMMARY：

Opiate refers to any drug that is derived from the opium poppy, including the natural products, morphine and codeine, and the semi-synthetic drugs such as heroin. Opioid is more general, referring to any drug that acts on the opioid receptor. Opioid analgesics comprise a large group of substances which control pain by depressing the central nervous system. Large doses of Morphine can produce higher tolerance levels and physiological dependency in users, and may lead to substance abuse. Morphine is excreted unmetabolized, and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose.

The OPI Urine Test is a rapid urine screening test that can be performed without the use of any instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Morphine in urine. Opiate Urine Test yields a positive result when Morphine in urine reaches 2000 ng/mL. This is the suggested screening cut-off for positive specimens set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA).